Skip to content

Clinical trials

Burkitt Lymphoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Country / region: Switzerland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20042
20052
20061
20071
20121
20161
20171
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status3
Terminated2
Active, not recruiting1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group6
European Organisation for Research and Treatment of Cancer - EORTC4
German High-Grade Non-Hodgkin's Lymphoma Study Group3
Gilead Sciences2
National Cancer Institute (NCI)2
Celgene1
Charite University, Berlin, Germany1
Kite, A Gilead Company1
Oncology Institute of Southern Switzerland1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma23
Precursor Cell Lymphoblastic Leukemia-Lymphoma15
Lymphoma14
Lymphoma, Large B-Cell, Diffuse12
Lymphoma, Follicular11
Lymphoma, Large-Cell, Immunoblastic10
Lymphoma, Mantle-Cell10
Lymphoma, Non-Hodgkin10
Lymphoma, B-Cell, Marginal Zone9
Leukemia, Lymphocytic, Chronic, B-Cell8

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.